AR019387A1 - ISOLATED POLYPEPTIDE, ISOLATED POLYNUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, PHARMACEUTICAL COMPOSITION, VACCINE, ISOLATED ANTIBODY, DIAGNOSTIC KIT, OLIGONUCLEOTIDE, METHOD OF INHIBITING THE CELLULAR PROJECTIVE DEVELOPMENT, METALLIC DEVELOPMENT - Google Patents

ISOLATED POLYPEPTIDE, ISOLATED POLYNUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, PHARMACEUTICAL COMPOSITION, VACCINE, ISOLATED ANTIBODY, DIAGNOSTIC KIT, OLIGONUCLEOTIDE, METHOD OF INHIBITING THE CELLULAR PROJECTIVE DEVELOPMENT, METALLIC DEVELOPMENT

Info

Publication number
AR019387A1
AR019387A1 ARP990103445A AR019387A1 AR 019387 A1 AR019387 A1 AR 019387A1 AR P990103445 A ARP990103445 A AR P990103445A AR 019387 A1 AR019387 A1 AR 019387A1
Authority
AR
Argentina
Prior art keywords
development
isolated
projective
vaccine
oligonucleotide
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/115,453 external-priority patent/US6657056B2/en
Priority claimed from US09/116,134 external-priority patent/US7008772B1/en
Priority claimed from US09/159,812 external-priority patent/US6613872B1/en
Priority claimed from US09/232,880 external-priority patent/US7270980B2/en
Priority claimed from US09/232,149 external-priority patent/US6465611B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AR019387A1 publication Critical patent/AR019387A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen composiciones y métodos para la terapia y el diagnostico de cáncer, tal como cáncer de prostata. Las composiciones pueden comprender una o másproteínas tumorales prostáticas, porciones inmunogénicas de las mismas o polinucleotidos que codifican dichas porciones. Como alternativa, la composicionterapéutica puede comprender una célula que presenta antígenos que expresan una proteína tumoral prostática o una célula T que es específica para células queexpresan dicha proteína. Dichas composiciones se pueden utilizar, por ejemplo, para la prevencion y el tratamiento de enfermedades como el cáncer de prostata.También se proveen métodos de diagnostico basados en la deteccion de una proteína tumoral prostática, o ARNm codificador de dicha proteína, en una muestra.Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are described. The compositions may comprise one or more prostate tumor proteins, immunogenic portions thereof or polynucleotides encoding said portions. Alternatively, the therapeutic composition can comprise a cell that has antigens that express a prostate tumor protein or a T cell that is specific for cells that express said protein. Such compositions can be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on the detection of a prostate tumor protein, or mRNA encoding said protein, are also provided in a sample.

ARP990103445 1998-07-14 1999-07-14 ISOLATED POLYPEPTIDE, ISOLATED POLYNUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, PHARMACEUTICAL COMPOSITION, VACCINE, ISOLATED ANTIBODY, DIAGNOSTIC KIT, OLIGONUCLEOTIDE, METHOD OF INHIBITING THE CELLULAR PROJECTIVE DEVELOPMENT, METALLIC DEVELOPMENT AR019387A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/115,453 US6657056B2 (en) 1997-02-25 1998-07-14 Compounds for immunotherapy of prostate cancer and methods for their use
US09/116,134 US7008772B1 (en) 1997-02-25 1998-07-14 Compounds for immunodiagnosis of prostate cancer and methods for their use
US15982298A 1998-09-23 1998-09-23
US09/159,812 US6613872B1 (en) 1997-02-25 1998-09-23 Compounds for immunotherapy of prostate cancer and methods for their use
US09/232,880 US7270980B2 (en) 1997-02-25 1999-01-15 Compounds for immunodiagnosis of prostate cancer and methods for their use
US09/232,149 US6465611B1 (en) 1997-02-25 1999-01-15 Compounds for immunotherapy of prostate cancer and methods for their use
US28894699A 1999-04-09 1999-04-09

Publications (1)

Publication Number Publication Date
AR019387A1 true AR019387A1 (en) 2002-02-13

Family

ID=44768811

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103445 AR019387A1 (en) 1998-07-14 1999-07-14 ISOLATED POLYPEPTIDE, ISOLATED POLYNUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, PHARMACEUTICAL COMPOSITION, VACCINE, ISOLATED ANTIBODY, DIAGNOSTIC KIT, OLIGONUCLEOTIDE, METHOD OF INHIBITING THE CELLULAR PROJECTIVE DEVELOPMENT, METALLIC DEVELOPMENT

Country Status (2)

Country Link
AR (1) AR019387A1 (en)
TW (1) TW200815476A (en)

Also Published As

Publication number Publication date
TW200815476A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
AR032743A1 (en) COMPOSITIONS AND METHODS FOR CANCER DE PULMON THERAPY AND DIAGNOSIS
TR200103560T2 (en) Compositions for the diagnosis and treatment of breast cancer and their use
ATE353974T1 (en) METHODS, COMPOSITIONS AND KITS FOR IDENTIFYING AND MONITORING BREAST CANCER
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
BR0113491A (en) Isolated polynucleotide and polypeptide, expression vector, host cell, fusion protein, methods for stimulating and / or expanding tumor protein-specific T cells to stimulate an immune response in a patient, to treat cancer in a patient and to inhibit cancer development in a patient, isolated t-cell population, composition, and use of a component.
BR0110091A (en) Compositions and processes for breast cancer therapy and diagnosis
HUP0500345A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001034802A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
HUP0302532A2 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001096388A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001096390A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2000060077A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
EA200501206A1 (en) DERIVATIONS FROM SURVIVIN PEPTIDES AND THEIR APPLICATION
EP1715043A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
EA201591219A1 (en) ANTIBODIES AGAINST LAMP1 AND CONJUGATES ANTIBODIES AND MEDICINES AND THEIR APPLICATION
AR029540A1 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND THERAPY OF CA NCER DE PULMoN
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
HUP0302566A2 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2001057207A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001051513A3 (en) Ovarian tumor-associated sequences
AR019387A1 (en) ISOLATED POLYPEPTIDE, ISOLATED POLYNUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, PHARMACEUTICAL COMPOSITION, VACCINE, ISOLATED ANTIBODY, DIAGNOSTIC KIT, OLIGONUCLEOTIDE, METHOD OF INHIBITING THE CELLULAR PROJECTIVE DEVELOPMENT, METALLIC DEVELOPMENT
AR029547A1 (en) COMPOSITIONS AND METHODS FOR CANCER DE PULMON THERAPY AND DIAGNOSIS
WO2001073031A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2002045657A3 (en) Ovarian tumor antigen and methods of use therefor

Legal Events

Date Code Title Description
FB Suspension of granting procedure